Physician profile
Patrick Whitman
NPI 1134764145
$4,221.27
in general payments reported to CMS, 2019-2025
23 companies · $927 in 2025
The $927 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,071 · 2023: $1,412 · 2024: $811 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,691 · Education: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,691.02 |
| Education | $458.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,214.80 | 2022-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $388.43 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $330.59 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $318.73 | 2022-2025 | |
| Abbvie INC. | $309.81 | 2023-2025 | |
| Incyte Corporation | $255.69 | 2022-2025 | Opzelura |
| Lilly USA, LLC | $171.53 | 2022-2025 | Olumiant, Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $168.45 | 2022-2024 | Winlevi, Absorica Ld |
| Ucb, INC. | $153.20 | 2022-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $136.15 | 2022-2023 | Aklief, Twyneo, Epsolay |
| Leo Pharma INC. | $128.06 | 2022 | |
| Amgen INC. | $107.14 | 2023-2024 | Otezla, Enbrel |
| Epi Health, LLC | $102.52 | 2022 | |
| Organon LLC | $84.23 | 2025 | Vtama |
| Pfizer INC. | $74.80 | 2022-2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $70.42 | 2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $62.78 | 2024-2025 | Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $32.27 | 2025 | Cabtreo, Siliq |
| Journey Medical Corporation | $30.28 | 2022-2023 | |
| Almirall LLC | $23.52 | 2022 | |
| Mayne Pharma Commercial LLC | $20.96 | 2023 | |
| Kyowa Kirin, INC. | $20.27 | 2022 | |
| Genentech USA, INC. | $16.64 | 2024 | Actemra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Whitman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.